Ceva Animal Health has announced the addition of a new CPD module to its Cardio Academy, covering the clinical significance of heart murmurs in cats.
Hosted by Virginia Luis-Fuentes, Professor of Veterinary Cardiology at the Royal Veterinary College, the online seminar provides guidance in deciding which heart murmurs are significant and working out which are more likely to develop complications, such as congestive heart failure or aortic thromboembolism.
According to the company, up to 40% of cats will have heart murmur at some point in their life, but are often clinically normal at presentation. To make things more confusing, says Ceva, 50% of cats with congestive heart failure do not have a heart murmur at all.
The module lasts for 20 minutes and, after viewing, delegates receive a CPD certificate by answering questions relating to the session.
To access this module, and 20 hours of online cardiology CPD, visit www.cardioacademy.cevalearn.com.
Vétoquinol, manufacturer of Epiphen (phenobarbital), for the control of epilepsy in dogs, has announced the launch of a new starter pack for clients that are embarking on treatment.
The starter packs contain a variety of support materials designed to help owners better understand the condition and its treatment. They sit alongside other support given by the company, which includes an 'Ask the Expert' helpline through which Epiphen veterinary customers can speak to a neurology specialist at The Animal Health Trust in Newmarket, where Vetoquinol sponsors a neurology clinician.
Abbie King, Product Manager for Epiphen, said: ''Our 'Ask the Expert' helpline is a successful service that has been running for several years. 30% of the calls to Vetoquinol's technical team relate to this challenging condition meaning there are few queries our technical team have not tackled before. If extra help is necessary we have an excellent working relationship with The Animal Health Trust and regularly refer cases to them for further advice. We are very proud of this service and are delighted to be able to continue to provide this helpline for our Epiphen clients.''
To use the 'Ask the Expert' service, or order the support materials, ring 0800 1698197. Alternatively visit: www.vetoquinol.co.uk or www.epiphenonline.co.uk.
The app gives users the ability to find information on over 1000 animal medicine listings included on the compendium website; with the complete datasheets available for viewing.
The new app also allows you to scan datamatrix barcodes on veterinary medicinal product packaging to take you straight to important product information. You can also search by medication, manufacturer or GTIN.
Dawn Howard, NOAH’s Chief Executive said: "The NOAH Compendium is the recognised industry reference, and it is essential we fully utilise the information offered in the compendium with modern technology, whilst protecting the integrity and respect that it holds.
"The website, which we relaunched earlier this year, has had over 8.5 million views to date. We feel this app serves as a great addition to this modern method of accessing data – meaning users are no longer reliant on internet access to obtain the information they need.
"As an organisation, we will continue to embrace new technologies to ensure animal medicine is used correctly and responsibly in the UK. The launch of this new app goes towards ensuring all those who prescribe or use animal medicines have access to the latest technical information available for companion and farm animals when they need it."
Lynda Maris, NexGard™ Spectra Product Manager said: "The campaign, which is designed to raise awareness of the rising threat from ticks, lungworm and other parasites that can endanger the health of pets and their owners, is reaching millions of pet owners."
A radio day, during which presenter Jenni Falconer and Merial vet Mike Woodhouse (pictured) discussed parasites and called on owners to visit their practice, apparently reached nearly 3 million listeners via 16 radio stations from BBC Radio Guernsey in the south, to Waves radio in Peterhead and Aberdeen.
The campaign has also been promoted with advertising on Newslink, which broadcasts to 287 stations including: Kiss, Capital, Star, Magic, Talk Sport, Classic and Absolute.
Participating practices have been send campaign support packs and Merial has provided educational and competition social media content to share on Facebook and Twitter. According to the company, its campaign Facebook page has reached reached over 1 million unique users in the last 28 days. Over the same period, Merial says 25,000 unique users have received campaign content on Twitter.
Practices can also direct clients to the campaign website www.petparasiteaction.co.uk.
Pet Parasite Action runs throughout June and July, so there's still time to get involved. For more information, contact your Merial Territory Manager, or call the company on 0870 6000 123.
The support pack is available now for existing stockists; others can sign up for a pack (whilst stocks last) at the London Vet Show in November, where Lintbells will be at stand U50.
According to the company, an estimated 15% of canine cases presented at first opinion practices are musculoskeletal and cats are also commonly affected.1
The Mobility Matters support materials are designed to help practices communicate the issues to clients, both in the waiting area and consulting room and online. There are also resources to help behind the scenes with setting up the clinics, including the new guide.
Gemma Cunningham, Lintbells Product Marketing Executive said: "We’re keen to bring attention to nurse-led clinics, which are not just great for patients but great for business too. Measurable outcomes include client satisfaction, incremental sales and improved patient comfort or quality of life. We’ve taken into account existing barriers based on what veterinary teams have told us and created the pack to address those needs. Our Mobility Matters referral cards, which help vets signpost clients to the clinics are a brilliant example of how the pack can help teams work more effectively together."
For more information, contact Lintbells on 01462 790886.
Reference
Hill's Pet Nutrition is offering veterinary surgeons, vet students and nurses in the UK an opportunity to look round its Pet Nutrition Centre in Topeka, Kansas, via a live webcast to be delivered at 7pm on Tuesday 11th January 2011.
To join the webcast, which will last around 1.5 hours, go to http://www.fc-tv.com/webcast/keystone/hills/jan-11-11 and enter the password pnctour. This event is specifically for veterinary surgeons, veterinary students and veterinary nurses only.
Tim Dobbins, Associate Veterinary Affairs Manager said: "We look forward to our colleagues joining us for this special live webcast and hearing some of the latest thinking that explains the science behind some of our most exciting products."
Invicta Animal Health has launched a new identification service for ChroMyco Duo dermatophyte kits in partnership with Axiom Veterinary Laboratories.
Veterinary practices can now send positive ChroMyco plates to Axiom and receive a species identification report for the specially discounted price of £8.00.
Rob Watkins, Managing Director of Invicta Animal Health said: "We are delighted to launch this service in response to customer feedback. This enables practices to gain a positive dermatophyte diagnosis in as little as three to six days so that treatment can be commenced promptly. Then, by sending the plate to Axiom, the actual species can be subsequently identified.
Axiom, with its innovative microbiology department and dedication to quality combined with its reliable network of courier services and postal processing systems are the ideal laboratory to provide this service".
Submission forms are available free of charge from Invicta Animal Health 01403 791313. ChroMyco Duo dermatophyte test kits are available from wholesalers and priced at £25.00 for 5 kits.
Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.
The Cat Cabin Fever campaign will run for four weeks.
Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour. Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat. "However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment." Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR. For more information, visit: http://www.feliway.co.uk/.
Vets that took part in the Vet Charity Challenge 2013 have raised a total of £50,000 which was presented to three animal charities at the London Vet Show.
The Vet Charity Challenge took place in September, when 53 teams of four spent the day walking, running, cycling, kayaking and orienteering, along with a variety of mental tasks. The money it raised has been distributed between Hearing Dogs for Deaf People, SPANA and Animals Asia
Jason Rogers, BCF Technology Marketing Manager and one of the organisers said: "The response we got for the Challenge this year has been remarkable with double the number of teams we had in 2012. It was quite a sight to see over 200 people at the briefing at the start of the day. Everyone seemed to really enjoy themselves and get into the spirit of the event. The amount raised this year is truly amazing."
One of the participants, Kerry Lambert from Ashworth Veterinary Group, Hampshire said: "The day was both exhilarating and exhausting. It was very well organised and friendly."
Caitrina Harrison from Vétoquinol added: "As one of the sponsors for this year's Vet Charity Challenge, Vétoquinol had three of the 53 teams entered. The amazing team spirit, fun atmosphere and inter-company rivalry all contributed to a fantastic event. The day was well organised and certainly our three teams, had a fantastic time. We'll be back again next year!"
Speaking for the three charities that benefited from the donations, Deborah Bourne, Corporate Fundraiser from Hearing Dogs for Deaf People said: "We would like to say a huge thank you to all the sponsors and competitors who got involved with this year's inspirational Vet Charity Challenge! Thanks to the determination, team spirit and generosity of everyone who took part, the money raised from this fantastic event will enable us to train more life changing hearing dogs to support deaf adults and children across the UK."
Grove Referrals, an East Anglian referral centre for orthopaedics, spinal surgery and ophthalmology, has announced the completion of £1 million refurbishment.
The project was overseen by ECVS diplomat James Tattersall (above, left next to Simon Gilbert and Gordon Brown), an orthopaedic surgeon at the practice, and the practice now offers the following facilities:
Practice Director Gordon Brown MRCVS said: "As a Referral Centre, it is important that we offer the very best to our patients. The refurbishment has created a fantastic working environment with the latest technology available if needed 24/7.
"Working in the building while such extensive work was underway wasn't easy but it's well worth it now that our vision for the practice has been realised. We're delighted with the new facilities we can offer and are looking forward to showing them to our veterinary colleagues and clients in the months ahead."
Grove Referrals is based at Grove House, Holt Road, Fakenham, Norfolk, NR21 8JG. The practice can be contacted on 01328 862137 or at grove.referrals@cvsvets.com
Norbrook Laboratories has launched Cefimam DC intramammary ointment, a new dry cow preparation containing the 4th generation cephalosporin, cefquinome.
The company has also released a Polish language version of its Best Practice Guide for On-Farm Mastitis Control, in response to demand from producers with non-English speaking farm-hands.
Norbrook vet Chris Geddes said: "I believe this is the first time that such a guide has been produced to cater for farm-hands of a different nationality working within the UK. Good mastitis management starts with good education; giving everyone on the farm the same opportunity for learning the best techniques for prevention means that we help minimise incidences of mastitis, which costs the dairy industry millions of pounds in lost revenue every year.
"This prevention includes a thorough and consistent approach to dry cow management. The early drying off period is often a risky time, when pre-existing subclinical infections can bed-in. The cow is also at increased risk of gaining new infections due to lack of udder hygiene procedures that would normally occur at milking, and weakened immunity as she approaches calving. Our new cefquinome preparation is a valuable addition to have in the treatment armoury for dry cow management. It has broad-spectrum activity and high cellular penetration to help tackle hard-to-manage cases with the aim of returning to maximum productivity by the start of the milking season."
Cefimam DC will be available at all veterinary wholesalers in packs of 24x and 120x 8g intramammary tubes. Vets can obtain both English and Polish versions of the Best Practice Guide for On-Farm Mastitis Control from Territory Managers.
For further information or copies of the Best Practice Guide for On-Farm Mastitis Control in English or Polish, contact your Territory Manager or call Norbrook GB head office on 01536 741 147.
'The new discovery in feline communication' symposium was held during the ISFM (International Society of Feline Medicine) International Feline Congress from 8th - 10th August.
The symposium was presented by Professor Patrick Pageat DVM MSc PhD HDR Dipl ECAWBM-BM Hon Dipl CLECVe, who researched and developed both Feliway and Adaptil, and Dr Andy Sparkes BVetMed PhD DipECVIM MANZCVS MRCVS, veterinary consultant at ISFM.
Patrick presented ‘the science behind the new pheromone discovery’ and covered how it was developed, how it works and why it is a step up from the existing pheromone products. Andy followed with ‘Feliway Optimum: clinical evidence’ and featured the clinical data behind the new product and how it outperforms existing pheromones.
To register for ‘the new discovery in feline communication’ symposium on demand, which equates to one hour’s CPD, email cevauk@ceva.com.
A research project funded by The Horse Trust has made important discoveries about how two peptides regulate the inflammatory response in horses. This knowledge could help with the development of improved anti-inflammatory drugs, which are used to treat a wide range of conditions in horses.
The research project was led by Professor Fiona Cunningham at the Royal Veterinary College in Hertfordshire and Dr Karen Rickards at the Donkey Sanctuary in Sidmouth, assisted by Dr Andrew Brooks at the RVC, and by Dr Kirstie Pickles, now at the Royal (Dick) School of Veterinary Studies in Edinburgh.
Inflammation is associated with a wide range of equine diseases, including recurrent airway obstruction, laminitis and sweet itch. Anti-inflammatory drugs, such as glucocorticosteroids, mainly work by blocking the formation and/or actions of compounds produced in the horse's body that cause inflammatory responses. However, these drugs are not always effective and can have unwanted side effects.
This research, funded by The Horse Trust, aimed to find out more about two naturally-occurring peptides - chains of amino acids that are shorter than proteins - known as annexin-1 and CXCL8. Both have been shown to affect the inflammatory response but little research has been done on their effects in horses. In the long term, knowing more about these compounds could help in the development of new anti-inflammatory drugs with fewer side effects.
During inflammation, neutrophils (a type of white blood cell) stick to the cells lining blood vessels and migrate into inflamed tissue, where they ingest and break down harmful agents. Using techniques that mimic these events, CXCL8 was found to cause adherence and migration of horse neutrophils. However, when it was used in combination with another pro-inflammatory substance, neutrophil migration and adherence were markedly decreased. This suggests that attempts to reduce inflammation by blocking the actions of CXCL8 might not be as beneficial as had been thought.
At the start of the project, the researchers had no information about horse annexin-1, other than its gene sequence, so their first step was to develop a method to detect the peptide in white blood cells. They established that it was present and, as horse annexin-1 has not yet been synthesised, they used a synthetic peptide derived from annexin-1, Ac2-26, to look at the effects on horse neutrophils.
They found that Ac2-26 decreased neutrophil adherence and migration in response to other pro-inflammatory compounds, although at high concentrations the peptide itself caused some cell activation, thereby increasing inflammation. They also found that dexamethasone (a glucocorticosteroid) increased the levels of annexin-1 in cells, indicating that, as in humans, this class of drugs is likely to act in part through the formation of annexin-1.
These findings suggest that the use of compounds which mimic the actions of annexin-1 may have limitations as anti-inflammatory drugs. As glucocorticosteroids partly work by forming annexin-1, further research is needed in order to find out how annexin-1 will act in the horse's body and establish how its formation contributes to the beneficial effects of these drugs.
Professor Cunningham said: "This Horse Trust-funded research has resulted in some very interesting findings about how inflammatory cells are regulated in horses. The receptors that annexin-1 and CXCL8 act upon could be targets for new equine inflammatory drugs, but more research is needed first to fully understand their actions and how they produce these effects."
The team's research has been accepted for publication by the journal Veterinary Immunology & Immunopathology.
The University of Liverpool's School of Veterinary Science has released the results of research carried out in collaboration with the Royal Canin Research Centre in France, which shows that cats eat 15% less in the summer than the winter.
Researchers spent four years monitoring how much cats chose to eat. The 38 cats studied had a microchip on their collar which allowed them to take as much food as they wanted from a dispenser which only opened for them. At the same time, this microchip recorded how much the cat had eaten and when.
Veterinary surgeon and study author, Dr Alex German, said: "Cats, like many humans are more inclined to comfort eat when it's cold outside but, in their case, it's likely to be due to the extra energy they need to keep warm when out and about."
The study found that cats ate approximately 15% less food during summer, and the researchers concluded that the extra effort to keep warm in winter and the temptation to rest during hot summer days contributed to the swing in activity levels during the year.
The cats were all inhabitants of a centre in southern France where they were allowed to play and exercise outside all year round. The cats were of mixed breeds, ages and genders. Data on food was compared to the climate in the area using computer modelling to provide information about how the temperature changed over the year.
Seasonal food intake has also been examined in the past on farm animals, such as dairy cows, to establish new ways of increasing milk production, but this is the largest study that has yet taken place with domestic cats.
Dr German said: "People should consider the amount of food their cats need at different times of year as this can be part of helping them to maintain a healthy weight."
The paper was published in the journal PLOS One. http://dx.plos.org/10.1371/journal.pone.0096071
The Veterinary Capability and Capacity Project (VCCP) is co-chaired by the UK’s Chief Veterinary Officer Nigel Gibbens, RCVS Senior Vice-President Dr Chris Tufnell, and BVA Senior Vice-President Gudrun Ravetz. The project board also comprises the CVOs for Scotland, Wales and Northern Ireland, Sheila Voas, Christianne Glossop and Robert Huey, as well as the Animal and Plant Health Agency and the Food Standards Agency.
The project’s objective is to work with the veterinary sector to better understand the UK’s workforce needs and ensure that both the Government and veterinary businesses can continue to protect animal health and welfare, safeguard the food chain and maintain levels of public health and public services, and enable trade in animals and animal products.
The project will include a joint BVA-RCVS submission to the Migration Advisory Committee’s call for evidence on workforce issues post-Brexit. Three working groups have been set up within the project to look specifically at issues of veterinary resources, recruitment and retention.
The UK’s Chief Veterinary Officer, Nigel Gibbens, said: "Leaving the EU provides us with an opportunity to develop gold standard policies on animal welfare. The UK Government is determined to get a good Brexit deal for Britain and Ministers have been absolutely clear we will maintain our world-leading animal welfare standards.
"The VCCP is a great example of collaborative working between government, professional bodies and regulators to prepare for our exit from the European Union.
"I am pleased the Prime Minister has set out the government’s aim to secure the status of the veterinary workforce as a top priority as we leave the EU. The UK’s vets - both Official Veterinarians and those in the private sector - play a key role in protecting our country from endemic and exotic diseases, tackling outbreaks when they occur, safeguarding our animals and tackling global challenges like antibiotic resistance."
Chris Tufnell said: "Since the vote to leave the European Union last year the RCVS has been working in partnership with BVA to highlight to Government and others the potential workforce shortages that could arise from a loss of non-UK EU-qualified vets, particularly in public health work where they tend to predominate. Our position was highlighted in our Brexit Principles published earlier this year and at an event organised by us and the BVA at the Palace of Westminster for MPs and Peers.
"We are very glad that Defra is working proactively with us and BVA to understand the scale of the issues and map out the risks and opportunities and to help us plan for a number of different scenarios in advance so that we do not find ourselves in a position whereby animal health and welfare or public health might be compromised by workforce shortages."
BVA Senior Vice President Gudrun Ravetz said: "Vets provide the foundation for the UK’s high animal health and welfare, and make an essential contribution to the UK economy and wider society. Veterinary teams up and down the country support the UK’s 11 million pet-owning households; not a penny of the UK’s £12.7 billion livestock industry could be realised without vets; and vets are vital to facilitating UK trade, through health certification and controls, so that consumers have confidence in the food safety and welfare of the products they buy.
"Non-UK EU vets make up around 50% of our new workforce each year yet, since the EU referendum; we are facing increasing problems in recruiting and retaining EU colleagues to the UK. The impact of the loss of even a small percentage of the veterinary workforce could have serious repercussions on the practices, communities and industries that vets serve. This profession-wide project is pivotal to ensuring we have a veterinary workforce that can serve the UK’s needs post-Brexit."
The BVA’s Brexit and the veterinary profession report can be found at www.bva.co.uk/news-campaigns-and-policy/policy/future-of-the-profession/brexit/
To read the College’s Brexit Principles in full visit www.rcvs.org.uk/brexit
The Prime Minister has set out the government’s offer for EU citizens in the UK and UK nationals in the EU on their rights and status after the UK leaves the EU: https://www.gov.uk/government/publications/safeguarding-the-position-of-eu-citizens-in-the-uk-and-uk-nationals-in-the-eu
The government’s response to House of Lord’s EU Energy and Environment Sub-Committee’s inquiry into Brexit: Farm Animal Welfare also addresses veterinary capability post-Brexit:https://www.parliament.uk/documents/lords-committees/eu-energy-environment-subcommittee/Brexit-farm-animal-welfare/Gov-Brexit-farm-anim.pdf
The webinars will be presented by specialists in their respective fields; small animal oncologist Sara Verganti and clinical pathologists Francesco Cian and Roberta Rasotto.
Each 30-minute session will focus on a specific aspect of MCT diagnostics followed by a multidisciplinary Q&A. The sessions, which all start at 7:30pm, are:
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Mast cell tumours are the most common form of canine cutaneous neoplasia, although relatively simple to identify, knowing what diagnostic steps to take can be challenging. We believe this truly comprehensive bite size mini-series will provide vets with the confidence to navigate the diagnostic approach for their next MCTs."
For more information, contact your Virbac Territory Manager.
Jacqui Molyneux, SPVS President Elect, has announced details of the work she has been involved in to radically restructure and improve the training of veterinary nurses in the UK.
For the last 10 years the VN qualification has involved candidates sitting for an NVQ in veterinary nursing. This NVQ is however being phased out by the Government, whatever party that may be, from next September. The RCVS is therefore taking this opportunity to put in place a viable alternative qualification to improve and build upon the current structure.
Jacqui said: "We are coming from the standpoint that, worryingly, there is a dire shortage of RVNs available for practices to employ. If we do not take this opportunity to do something now, the situation will in all likelihood deteriorate even further.
"I chair a working party convened in May which has been looking at current VN training and how to improve it. There was an initial written period of information gathering followed by three full days of face-to-face consultation meetings with invited interested parties in July and September. This period of consultation has resulted in a proposal being put forward.
She added: "The proposals are radical and in some ways controversial but have been put together in response to the feedback we have received so far. I must, however, reiterate that it is, at this stage, a proposal and we are still in a consultation period.
"At the end of the period we will have another working party meeting and reassess the proposal. This will then go to the Awarding Body Board and on to both VN council and RCVS council for full approval. I hope we will end up with a scheme that reflects the vital role nurses play in a modern veterinary practice."
The consultation document can be found here.
CVS Group has announced that European internal medicine specialist Caroline Kisielewicz MVB CertSAM DipECVIM-CA is joining ChesterGates Veterinary Specialists with effect from 1 October 2014.
Caroline Kisielewicz graduated from University College, Dublin in 2006 and, after working in first opinion small animal practice for two years, completed an ECVIM-residency training programme at the Small Animal Hospital at the University of Glasgow in February 2013.
Most recently she has been working at the Queen Mother Hospital for Animals at the Royal Veterinary College. She is interested in all aspects of small animal internal medicine, particularly emergency medicine, transfusion medicine, immune-mediated diseases and endocrine diseases.
CVS Referral Director, Professor John Innes said: "We are delighted to welcome Caroline to our specialist team at ChesterGates. She is a rising star in internal medicine and I believe it is a measure of CVS' growing reputation for offering a diverse range of career options that we are attracting some of the strongest talent from the specialist vet pool.
"Caroline joins Ellie Mardell and Chris Saul here at ChesterGates to help us to offer an even more comprehensive and user-friendly internal medicine service."
Caroline said: "I was keen to join this excellent multi-disciplinary specialist referral hospital with its dynamic, friendly and close-knit team. Working at ChesterGates gives me the opportunity to provide the highest standard and quality of care and treatment for my patients, clients and their referring vets."
Luke will receive his award at the 2016 WSAVA World Congress, which takes place from 27-30 September in Cartagena, Colombia, where he will also give a lecture on his work, entitled ‘One Mission’.
The WSAVA Global One Health Award is presented by the WSAVA’s One Health Committee (OHC) to an individual who has promoted an aspect of One Health relevant to small companion animals.
Luke graduated from Bristol University in 1999 and is based in his New Forest surgery, Pilgrims Veterinary Practice. In 2003, he set up Worldwide Veterinary Service (WVS), a charity providing veterinary aid around the world, followed, in 2013, by sister charity, Mission Rabies, which is leading the battle against canine rabies and works closely with the WSAVA’s charitable Foundation. Luke is CEO of both organisations and has raised more than four million pounds to support the charities’ projects around the world. He lectures internationally on animal welfare and veterinary subjects and, in 2014, was asked by the World Health Organisation (WHO) to sit on an expert panel for the International Control of Neglected Zoonotic Diseases based on his rabies work globally.
Professor Michael Day, Chair of the WSAVA OHC, said: "The current most significant example of the importance of a One Health approach to disease control relates to the global fight against canine rabies - a disease that continues to cause an estimated minimum 59,000 human deaths each year. Luke is a world leader in this global fight. Mission Rabies runs mass vaccination campaigns and provides public education in Asia and Africa, having now vaccinated almost 400,000 dogs, spoken to over 500,000 schoolchildren and successfully controlled rabies in selected target areas.
"The Mission Rabies programme is grounded in solid evidence-based science, with the field data collected having now generated the first high-class scientific manuscripts. Luke is a truly inspirational and charismatic leader who believes in simply getting on with the job at hand. The achievements of Mission Rabies and its sister charity, Worldwide Veterinary Service, readily show that even the greatest global health challenges are not insurmountable."
Luke said: "It’s a huge honour to receive this Award and I accept it on behalf of an amazing team - without whom - the projects would be impossible. It’s an utter privilege to be a part of the veterinary profession and fighting diseases like rabies is an incredible opportunity to champion both animals and people – something we can all identify with. I’m totally indebted to WSAVA and the international veterinary community, whose support has been overwhelming, and it is only with this unity, that we can keep driving forward – and winning."
The survey was held in mid-June and gathered 196 responses from UK practices. That compared with the 532 responses to the initial survey conducted early in April and 251 responses to the second survey conducted at the start of May.
One of the main findings was a marked increase in the number of practices running a near-normal caseload, from 3% in May to 32% in June. Practice turnover data similarly reflected a shift back towards normality, with 46% now reporting a reduction of less than 25%, compared with 19% last month.
Other findings included:
Lizzie Lockett, RCVS CEO, said: "This latest survey has demonstrated a continuation of the previous survey’s positive trends including an increase in practice turnover with more practices approaching a ‘near normal caseload’ and with a reduction in the number of practices impacted by staff self-isolating or with confirmed cases of Covid-19.
“In this survey we also asked about what difficulties practices may be experiencing with EMS placements for vet students and VN training placements as a result of Covid-19, and this will help us to understand how we can better support students and practices in these areas.
“We will continue to monitor the situation via these regular surveys, with the next one planned for later this summer. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected and how they are recovering.
"This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
Genitrix has launched Dentagen, billed as the UK’s first dental plaque protection system for dogs and cats.
The active principle in Dentagen is a plant extract called RF2 and the product operates as an ‘anti-biofilm’ treatment by modifying the membrane of oral bacteria to prevent them from producing plaque even at low concentrations.
Dentagen wax is presented for practice use in a syringe for easy application to the gingival layer and the buccal area of teeth. The initial protective coating of wax is applied to dogs or cats at end of dental procedures in practice and while the animal is still sedated. The coating lasts for two to three days.
Dog owners can then maintain the protective coating by giving their pet Dentagen plaque prevention chews every other day. The chews, impregnated with RF2 and of a specially designed shape and consistency, are supplied in two sizes with the larger size designed for dogs over 8 kg and a smaller size for dogs less than 8 kg.
Vet Katy Horton of White Hart Lane Vets, who has trialled the product, commented: “The Dentagen wax was certainly very easy to apply and, from the small sample of dogs we’ve so far tried it on, the palatability of the chews was good. While tooth-brushing remains the gold standard for dental care, we recognise that it can be difficult for owners and believe that this new approach could be a valuable alternative.”
Five syringes of Dentagen for application in practice cost £12.50. Packs of nine small chews cost £5.10 while a pack of the larger chews costs £6.50.
Dechra Veterinary Products has reduced the price of two key products in its Veterinary Essentials range to help practices respond to the challenging economic climate.
Atipam 5 ml is now the same price per ml as Atipam 10ml. Used for the reversal of the sedative effects of medetomidine and dexmedetomidine in cats and dogs, practices can now choose the size that suits them best. Additionally, during January, for every 15ml purchased an extra 5ml will be provided to practices free of charge.
Thyroxyl, used for the treatment of hypothyroidism in dogs, has also been reduced in price by 15 per cent. Practices that include Thryoxyl as part of the newly introduced Essential Purchase Plan can also make further savings.
To find out more about the Veterinary Essentials range, including further costs savings with an Essentials Purchase Plan and free margin development advice, call Liz Rawlings on 01743 441632.
New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
The research was carried out by the Kansas State University College of Veterinary Medicine Center for Outcomes Research and Epidemiology, Holland Management Services, Zoetis and the Pet Insight Project team at Kinship (part of Mars Petcare).
For the study, researchers recorded pet scratching activity use Whistle canine activity trackers. They then compared that information with the visual observations of 358 pet owners who graded the severity of their pet’s scratching activity on a scale from 0, which represents a normal dog (“itching is not a problem for my dog”) to 100, corresponding to extreme itching (“itching disrupts my dog’s sleep, eating, play and exercise”).
The researchers found that measurements of scratching severity determined by the Whistle activity tracker corresponded to the owner’s overall impression of the pet’s pruritus, or itch, level. As scratching severity increased, as measured by the Whistle device, owner’s assessment scores significantly increased as well (P < 0.01).
Aletha Carson DVM, Data and Clinical Studies Senior Manager for Kinship said: “Pet owners can overlook the subtle changes in behaviour that may be a warning sign for an underlying issue and are often too late to recognise their beloved companion is suffering.
“This new method of analysing pet behaviours provides pet owners with an ‘always-on’ monitor that may be helpful in keeping their dogs healthy and happy.
“It may also prove to be quite useful for veterinarians who need an objective way to gauge a pet’s response to prescribed therapies used to reduce inflammation and scratching without requiring time-intensive monitoring from the owner.”
Details of the research were shared at the European Veterinary Dermatology Congress on September 17, 2021.
Freelance Surgical Ltd has announced a limited offer under which it will supply all of the instrumentation and capital equipment required for a veterinary practice to set up a new laparoscopy service, for £10,000 +VAT
The company says it has seen a substantial number of requests for laparoscopic instrumentation and capital devices in recent months. James Towler, Veterinary Director said: "Keyhole surgery is becoming increasingly popular within the veterinary field and the driving force is the client. They are now more informed of the benefits of what this type of surgery can offer. Our goal is to be able to provide veterinarians with an affordable package that will allow them to cater to client request s rather than referring the patient to their competitors."
Freelance Surgical says using laparoscopy has proven for many to generate a new revenue stream as well as offering improved patient outcomes. According to the company, a practice performing 6 bitch spays a week can generate over £50,000 in just 3 years*
For more information contact Freelance Surgical on 0845 050 4147or visit: www.freelance-veterinary.co.uk